99205147 - XERVYTEG

Information

• Trademark
• 99205147

• Source

• Serial Number

  99205147

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth

• Filing Date

  May 28, 2025
  5 months ago

• Transaction Date

  June 21, 2025
  4 months ago

• Status Date

  June 20, 2025
  4 months ago

• Location Date

  June 20, 2025
  4 months ago

• Status Code

  641

• Current Location

  TMO LAW OFFICE 112

  Employee Name

  GLUECK, CHRISTOPHER

• Attorney Docket Number

  083-003TM

  Attorney Name

  Jeffrey H. Greger

  Law Office Assigned Location Code

  M30

• Owners

  • MAAT PHARMA

Case File Statements

• DM0000: The mark consists of XERVYTEG in purple and in a stylized format.
• GS0051: Pharmaceutical and biopharmaceutical products and preparations for medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction, and for treating cancers and diseases, namely, neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases; Pharmaceuticals for treatment, maintaining and restoring human health in the field of disturbed microbial community, and treatment for dysbiosis, cancers, and diseases, including neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases; Biological preparations in the nature of microorganisms used to treat, maintain and restore human health in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, and diseases including neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases
• CC0000: The color(s) purple and yellow is/are claimed as a feature of the mark.
• GS0101: Medical and surgical apparatus and instruments; drug delivery devices, including medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations; Drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set

Case File Event Statements

• 5/28/2025 - 5 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/6/2025 - 5 months ago

  4 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 6/6/2025 - 5 months ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/18/2025 - 4 months ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 6/20/2025 - 4 months ago

  8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/20/2025 - 4 months ago

  7 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/20/2025 - 4 months ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/28/2025 - 5 months ago

  2 - APPLICATION FILING RECEIPT MAILED Type: MAFR